All Stories

  1. Multifactorial White Matter Damage in the Acute Phase and Pre-Existing Conditions May Drive Cognitive Dysfunction after SARS-CoV-2 Infection: Neuropathology-Based Evidence
  2. Histotype-Dependent Oligodendroglial PrP Pathology in Sporadic CJD: A Frequent Feature of the M2C “Strain”
  3. Greenfield's Neuropathology - Two Volume Set
  4. Distinctive cerebral neuropathology in an adult case of sensory ataxic neuropathy with dysarthria and ophthalmoplegia (SANDO) syndrome
  5. K27/G34 versus K28/G35 in histone H3-mutant gliomas: A note of caution
  6. Iatrogenic Creutzfeldt–Jakob disease
  7. Phenotypic and functional complexity of brain-infiltrating T cells in Rasmussen encephalitis
  8. Comorbidity and prognosis in disproportionately enlarged subarachnoid space hydrocephalus (DESH-iNPH): Japanese and Austrian cohort studies
  9. Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG)
  10. SAMP8 mice as a neuropathological model of accelerated brain aging and dementia: Toshio Takeda's legacy and future directions
  11. Cystatin F is a biomarker of prion pathogenesis in mice
  12. Fatal childhood hypertension
  13. Tau pathology in Creutzfeldt-Jakob disease revisited
  14. Neuropathological criteria of anti-IgLON5-related tauopathy
  15. Prion diseases
  16. Prion 2016 Oral Abstracts
  17. Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant
  18. Amyloid-β pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting
  19. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy
  20. The end of the BSE saga: do we still need surveillance for human prion diseases?
  21. Iatrogenic and sporadic Creutzfeldt-Jakob disease in 2 sisters without mutation in the prion protein gene
  22. Structure-based drug design identifies polythiophenes as antiprion compounds
  23. Molecular Genetics of Creutzfeldt-Jakob Disease and Gerstmann- Sträussler- Scheinker Disease
  24. A Genome Wide Association Study Links Glutamate Receptor Pathway to Sporadic Creutzfeldt-Jakob Disease Risk
  25. Reduction in Serum Aquaporin-4 Antibody Titers During Development of a Tumor-Like Brain Lesion in a Patient With Neuromyelitis Optica: A Serum Antibody–Consuming Effect?
  26. A case of variably protease-sensitive prionopathy treated with doxycyclin
  27. The Role of the NADPH Oxidase NOX2 in Prion Pathogenesis
  28. MRI features of Binswanger's disease predict prognosis and associated pathology
  29. Intracellular processing of disease-associated α-synuclein in the human brain suggests prion-like cell-to-cell spread
  30. Disproportionate subarachnoid space hydrocephalus—outcome and perivascular space
  31. ISN Information Days at the University of Witwatersrand Medical School, Johannesburg (South Africa) on September 23rd-24th, 2013
  32. Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP: a new disease entity?
  33. Prion diseases: an introduction
  34. JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment
  35. Globular glial tauopathies (GGT): consensus recommendations
  36. Intensity of human prion disease surveillance predicts observed disease incidence
  37. Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series
  38. Imported human rabies in Switzerland, 2012: A diagnostic conundrum
  39. Cerebellar dysfunction in a family harboring the PSEN1 mutation co-segregating with a Cathepsin D variant p.A58V
  40. Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium
  41. Neuropathology
  42. Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositis
  43. External granular cell layer bobbling: a distinct histomorphological feature of the developing human cerebellum
  44. Gerstmann–Sträussler–Scheinker Disease
  45. The need to unify neuropathological assessments of vascular alterations in the ageing brain
  46. The Spectrum of Tau Pathology in Human Prion Disease
  47. Risk assessment of biological hazards for consumer protection
  48. Stabilization of a Prion Strain of Synthetic Origin Requires Multiple Serial Passages
  49. Scientific Opinion on Reflecting on the experiences and lessons learnt from modelling on biological hazards
  50. Scientific Opinion on the development of a risk ranking framework on biological hazards
  51. Obituary: In Memoriam: Professor John Daniel Collins
  52. Scientific Opinion on a review on the European Union Summary Reports on trends and sources zoonoses, zoonotic agents and food‐borne outbreaks in 2009 and 2010 – specifically for the data on Salmonella, Campylobacter, verotoxigenic Escherichia coli, Lis...
  53. A New Mechanism for Transmissible Prion Diseases
  54. Scientific Opinion on Public health risks represented by certain composite products containing food of animal origin
  55. Scientific Opinion on the evaluation of new TSE rapid tests submitted in the framework of the Commission Call for expression of interest 2007/S204-247339
  56. Creutzfeldt-Jakob disease with unusually extensive neuropathology in a child treated with native human growth hormone
  57. Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infection
  58. Antibody 9D5 Recognizes Oligomeric Pyroglutamate Amyloid-β in a Fraction of Amyloid-β Deposits in Alzheimer's Disease without Cross-Reactivity with other Protein Aggregates
  59. Novel crystalloid oligodendrogliopathy in hereditary spastic paraplegia
  60. Scientific Opinion on the minimum hygiene criteria to be applied to clean seawater and on the public health risks and hygiene criteria for bottled seawater intended for domestic use
  61. Statement on a request from the European Commission for the assessment of the scientific elements supporting the prohibition for the placing on the market of GM potato EH92‐527‐1 for cultivation purposes in Austria
  62. Intraneuronal Immunoreactivity for the Prion Protein Distinguishes a Subset of E200K Genetic From Sporadic Creutzfeldt-Jakob Disease
  63. Advocacy for Neuropathology in practice: ISN Information Days
  64. An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology
  65. Scientific Opinion on Composting and incineration of dead-on-farm pigs
  66. Asymmetry of neurodegenerative disease-related pathologies: a cautionary note
  67. Scientific Opinion on Norovirus (NoV) in oysters: methods, limits and control options
  68. Scientific Opinion on the maintenance of the list of QPS biological agents intentionally added to food and feed (2011 update)
  69. Genesis of Mammalian Prions: From Non-infectious Amyloid Fibrils to a Transmissible Prion Disease
  70. Fatal Prion Disease in a Mouse Model of Genetic E200K Creutzfeldt-Jakob Disease
  71. Scientific Opinion on On-site treatment of pig carcasses
  72. Scientific Opinion on Isolation in proofed pit on-farm of dead poultry
  73. Multiple intracranial cavernomas with focal amyloid deposition – diagnostic pitfalls
  74. Scientific Opinion on the public health hazards to be covered by inspection of meat (swine)
  75. Scientific Opinion on risk based control of biogenic amine formation in fermented foods
  76. Sporadic Creutzfeldt-Jakob Disease
  77. Complex tauopathies vs. tangle predominant dementia
  78. Editorial: The European Response to BSE: A Success Story
  79. Scientific Opinion on the evaluation of a new processing method for ABP Category 2 materials of fish origin
  80. Advocacy for Neuropathology
  81. Scientific Opinion on the public health risks of bacterial strains producing extended-spectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animals
  82. Scientific Opinion on assessment of epidemiological data in relation to the health risks resulting from the presence of parasites in wild caught fish from fishing grounds in the Baltic Sea
  83. Scientific Opinion on a quantitative estimation of the public health impact of setting a new target for the reduction of Salmonella in broilers
  84. Scientific Opinion on Hatchery Waste as animal by‐products
  85. Long-term clinical improvement of progressive multifocal leukoencephalopathy associated with prominent inflammatory response and follicular lymphoma
  86. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
  87. Scientific Opinion on a summary of scientific studies undertaken by the UK Food Standards Agency to support a proposed production method for smoked “skin-on” sheep meat
  88. Peroxisomal alterations in Alzheimer’s disease
  89. Fibulin-5 mutations link inherited neuropathies, age-related macular degeneration and hyperelastic skin
  90. Scientific Opinion onCampylobacterin broiler meat production: control options and performance objectives and/or targets at different stages of the food chain
  91. Scientific Opinion on the efficacy and microbiological safety of irradiation of food
  92. New lexicon and criteria for the diagnosis of Alzheimer's disease
  93. Compassion for our colleagues and friends in Japan
  94. A peculiar constellation of tau pathology defines a subset of dementia in the elderly
  95. Scientific Opinion on a review of the BSE-related risk in bovine intestines
  96. Joint Scientific Opinion on any possible epidemiological or molecular association between TSEs in animals and humans
  97. Scientific Opinion on the revision of the quantitative risk assessment (QRA) of the BSE risk posed by processed animal proteins (PAPs)
  98. Unclassifiable tauopathy associated with an A152T variation in MAPT exon 7
  99. Prediction of Preadolescent Depressive Symptoms From Child Temperament, Maternal Distress, and Gender: Results of a Prospective, Longitudinal Study
  100. Post-Salzburg Blues vs. Rise to New Horizons?
  101. Scientific Opinion on BSE/TSE infectivity in small ruminant tissues
  102. Scientific Opinion on a second update on the risk for human and animal health related to the revision of the BSE monitoring regime in some Member States
  103. Scientific Opinion on the maintenance of the list of QPS biological agents intentionally added to food and feed (2010 update)
  104. Ultrastructural Characteristics (or Evaluation) of Creutzfeldt-Jakob Disease and Other Human Transmissible Spongiform Encephalopathies or Prion Diseases
  105. Scientific Opinion on the results of the EU survey for Chronic Wasting Disease (CWD) in cervids
  106. Scientific Opinion on Fish Oil for Human Consumption. Food Hygiene, including Rancidity
  107. Scientific Opinion on monitoring and assessment of the public health risk of “SalmonellaTyphimurium-like” strains
  108. Scientific Opinion on the Neste Oil Application for a new alternative method of disposal or use of Animal By-Products
  109. Peroxisomal Localization of the Proopiomelanocortin-Derived Peptides β-Lipotropin and β-Endorphin
  110. Viral Meningo-Encephalitis
  111. Scientific Opinion on the safety and efficacy of using recycled hot water as a decontamination technique for meat carcasses
  112. Increased neuronal Rab5 immunoreactive endosomes do not colocalize with TDP-43 in motor neuron disease
  113. Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases
  114. Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis
  115. Welcome to ICN 2010
  116. Scientific Opinion on Lime Treatment of Solid Pig and Poultry Manure
  117. Statement on technical assistance on the format for applications for new alternative methods for animal by‐products
  118. Genetic Creutzfeldt-Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy
  119. Statement on Food safety considerations of novel H1N1 influenza virus infections in humans
  120. Prion Diseases
  121. Subacute and Chronic Viral Infections
  122. Scientific Opinion on Q fever
  123. Scientific Opinion on risk assessment of parasites in fishery products
  124. Scientific Opinion on a quantitative estimation of the public health impact of setting a new target for the reduction of Salmonella in laying hens
  125. Scientific Opinion on a Quantitative Microbiological Risk Assessment of Salmonella in slaughter and breeder pigs
  126. Scientific Opinion on Analytical sensitivity of approved TSE rapid tests – new data for assessment of two rapid tests
  127. Distribution of apoptosis-related proteins in sporadic Creutzfeldt–Jakob disease
  128. Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics
  129. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management
  130. Scientific Opinion on the link between Salmonella criteria at different stages of the poultry production chain
  131. Status of ICN 2010
  132. Recombinant prion protein induces a new transmissible prion disease in wild-type animals
  133. Scientific Opinion on Quantification of the risk posed by broiler meat to human campylobacteriosis in the EU
  134. Cathepsin D (C224T) Polymorphism in Sporadic and Genetic Creutzfeldt-Jakob Disease
  135. Genetic Creutzfeldt-Jakob disease mimicking variant Creutzfeldt-Jakob disease
  136. In vivo expression of proinflammatory cytokines in HIV encephalitis: an analysis of 11 autopsy cases
  137. No evidence for cognitive dysfunction or depression in patients with mild restless legs syndrome
  138. TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea
  139. Danon disease: Case report and detection of new mutation
  140. Inter-Laboratory Assessment of PrPScTyping in Creutzfeldt-Jakob Disease: A Western Blot Study within the NeuroPrion Consortium
  141. S1‐02‐05: Reproducibility in the assessment of Alzheimer's disease and Lewy body disease‐related pathologies: A study by Brain Net Europe
  142. Molecular Pathology of Human Prion Diseases
  143. Reduced Expression of Excitatory Amino Acid Transporter 2 and Diffuse Microglial Activation in the Cerebral Cortex in AIDS Cases With or Without HIV Encephalitis
  144. Ultrastructural study of florid plaques in variant Creutzfeldt-Jakob disease: a comparison with amyloid plaques in kuru, sporadic Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker disease
  145. BSE and TSEs: Past, present and future
  146. Accumulation of HtrA2/Omi in Neuronal and Glial Inclusions in Brains With α-Synucleinopathies
  147. White Matter Tauopathy With Globular Glial Inclusions: A Distinct Sporadic Frontotemporal Lobar Degeneration
  148. Excretion of Transmissible Spongiform Encephalopathy Infectivity in Urine
  149. Nigral burden of α-synuclein correlates with striatal dopamine deficit
  150. The role of parvalbumin and calbindin D28k in experimental scrapie
  151. Endothelial and Myogenic Differentiation of Hematopoietic Progenitor Cells in Inflammatory Myopathies
  152. Intrathecal anti-αB-crystallin IgG antibody responses: Potential inflammatory markers in Guillain-Barré syndrome
  153. Assessment of the possible effect of the four antimicrobial treatment substances on the emergence of antimicrobial resistance - Scientific Opinion of the Panel on Biological Hazards
  154. Neocortical neurones may be targeted by immune attack in anti-Yo paraneoplastic syndrome
  155. Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium
  156. Inter-laboratory comparison of neuropathological assessments of β-amyloid protein: a study of the BrainNet Europe consortium
  157. Prion Diseases: From Protein to Cell Pathology
  158. Tubulovesicular structures are a consistent (and unexplained) finding in the brains of humans with prion diseases
  159. Assessment of α-Synuclein Pathology: A Study of the BrainNet Europe Consortium
  160. A quantitative microbiological risk assessment on Salmonella in meat : Source attribution for human salmonellosis from meat - Scientific Opinion of the Panel on Biological Hazards
  161. Biological Safety of a Process for the Hydrolysis on-Farm of Dead Pigs - Scientific Opinion of the Panel on Biological Hazards
  162. Biological Safety of a Process for the Hydrolysis on-Farm of Dead Rabbits - Scientific Opinion of the Panel on Biological Hazards
  163. Iatrogenic Creutzfeldt Jakob disease 22 years after human growth hormone therapy: clinical and radiological features
  164. Creutzfeldt-Jakob Disease in Austria: An Autopsy-Controlled Study
  165. Mixed Brain Pathologies in Dementia: The BrainNet Europe Consortium Experience
  166. DEAR READER
  167. Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: Implications for X-linked adrenoleukodystrophy
  168. Verbal perseveration as the initial symptom in a case of Creutzfeldt‐Jakob disease
  169. Papillary glioneuronal tumor
  170. Bilateral striopallidodentate calcification (Fahr's syndrome) and multiple system atrophy in a patient with longstanding hypoparathyroidism
  171. Fatal Neurological Disease in Scrapie-Infected Mice Induced for Experimental Autoimmune Encephalomyelitis
  172. Effects of Formalin Fixation, Paraffin Embedding, and Time of Storage on DNA Preservation in Brain Tissue: A BrainNet Europe Study
  173. Errata
  174. Involvement of the Endosomal-Lysosomal System Correlates With Regional Pathology in Creutzfeldt-Jakob Disease
  175. Immunohistochemical detection of class III ?-tubulin in primary brain tumours: variable expression in most tumour types limits utility as a differential diagnostic marker
  176. Autopsy at 2 months after death: Brain is satisfactorily preserved for neuropathology
  177. Fulminant central nervous system demyelination associated with interferon-α therapy and hepatitis C virus infection
  178. Malignant predominantly minigemistocytic glioma in two infants: a distinctive glioma variant?
  179. Secretagogin expression in tumours of the human brain and its coverings
  180. Accumulation of Hsc70 and Hsp70 in glial cytoplasmic inclusions in patients with multiple system atrophy
  181. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms
  182. Synucleinopathy with features of both multiple system atrophy and dementia with Lewy bodies
  183. Brain Protein Preservation Largely Depends on the Postmortem Storage Temperature
  184. How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II
  185. TPPP/p25 in brain tumours: expression in non-neoplastic oligodendrocytes but not in oligodendroglioma cells
  186. The brain-specific protein TPPP/p25 in pathological protein deposits of neurodegenerative diseases
  187. Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993–2002
  188. Histopathological prognostic factors in medulloblastoma: High expression of survivin is related to unfavourable outcome
  189. Immunohistochemical Analysis of INI1 Protein in Malignant Pediatric CNS Tumors: Lack of INI1 in Atypical Teratoid/Rhabdoid Tumors and in a Fraction of Primitive Neuroectodermal Tumors without Rhabdoid Phenotype
  190. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease
  191. Interlaboratory Comparison of Assessments of Alzheimer Disease-Related Lesions: A Study of the BrainNet Europe Consortium
  192. Inflammatory response in human tick-borne encephalitis: analysis of postmortem brain tissue
  193. P3-198
  194. P4-152
  195. Immunohistochemical Expression of Prion Protein (PrPC) in the Human Forebrain During Development
  196. Prominent corticosteroid disturbance in experimental prion disease
  197. Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein
  198. Introduction
  199. The Austrian FFI Cases
  200. Endoplasmic Reticulum Stress Features Are Prominent in Alzheimer Disease but Not in Prion Diseases In Vivo
  201. UPDATE ON TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
  202. Comparative analysis of NeuN immunoreactivity in primary brain tumours: conclusions for rational use in diagnostic histopathology
  203. Prions in Humans and Animals
  204. Upregulated Expression of 14-3-3 Proteins in Astrocytes From Human Cerebrovascular Ischemic Lesions
  205. Acute motor and sensory axonal neuropathy in Burkitt-like lymphoma
  206. Survivin Expression in Intracranial Ependymomas and Its Correlation With Tumor Cell Proliferation and Patient Outcome
  207. Genetic prion disease: the EUROCJD experience
  208. Immunohistochemical Analysis of Platelet-derived Growth Factor Receptor-α, -β, c-kit, c-abl, and Arg Proteins in Glioblastoma: Possible Implications for Patient Selection for Imatinib Mesylate Therapy
  209. Prion disease with a 144 base pair insertion: unusual cerebellar prion protein immunoreactivity
  210. Pleomorphic xanthoastrocytoma with anaplastic features presenting without GFAP immunoreactivity: Implications for differential diagnosis
  211. Redox metals and oxidative abnormalities in human prion diseases
  212. The ubiquitin–proteasome system in Creutzfeldt–Jakob and Alzheimer disease: Intracellular redistribution of components correlates with neuronal vulnerability
  213. Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting
  214. Megadolichobasilar anomaly with thrombosis in a family with Fabry's disease and a novel mutation in the α-galactosidase A gene
  215. UPDATE ON THE PATHOGENESIS OF TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
  216. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada
  217. Viral encephalitis: a review of diagnostic methods and guidelines for management
  218. No prognostic impact of survivin expression in glioblastoma
  219. Pathogenesis of prion diseases
  220. Imaging ex vivo healthy and pathological human brain tissue with ultra-high-resolution optical coherence tomography
  221. Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival
  222. Presence of D110 antigen expressing immunocompetent cells in glioblastoma associates with prolonged survival
  223. Neuropathology of white matter disease in Leber's hereditary optic neuropathy
  224. Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies
  225. The prion protein in human neuromuscular diseases
  226. 14-3-3 proteins in Lewy body-like hyaline inclusions in patients with sporadic amyotrophic lateral sclerosis
  227. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies
  228. Enhanced expression of 14-3-3 proteins in reactive astrocytes in Creutzfeldt-Jakob disease brains
  229. Ki-67 Immunolabeling Index Is an Accurate Predictor of Outcome in Patients With Intracranial Ependymoma
  230. Value and limits of immunohistochemistry in differential diagnosis of clear cell primary brain tumors
  231. Standards for the assay of Creutzfeldt-Jakob disease specimens
  232. Meeting report
  233. Topographical and cytopathological lesion analysis of the white matter in Binswanger?s disease brains
  234. Advances in broad bandwidth light sources for ultrahigh resolution optical coherence tomography
  235. Complement activation in human prion disease
  236. Increased 14-3-3 immunoreactivity in glial elements in patients with multiple sclerosis
  237. Antigenic profile of human recombinant PrP: generation and characterization of a versatile polyclonal antiserum
  238. Rationale for diagnosing human prion disease
  239. Creutzfeldt-Jakob disease and inclusion body myositis: Abundant disease-associated prion protein in muscle
  240. Rosette-forming glioneuronal tumor of the fourth ventricle
  241. Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barre syndrome
  242. Fluorescent In Situ Hybridization on Isolated Tumor Cell Nuclei: A Sensitive Method for 1p and 19q Deletion Analysis in Paraffin-Embedded Oligodendroglial Tumor Specimens
  243. D18G Transthyretin Is Monomeric, Aggregation Prone, and Not Detectable in Plasma and Cerebrospinal Fluid:  A Prescription for Central Nervous System Amyloidosis?†
  244. Molecular classification of sporadic Creutzfeldt–Jakob disease
  245. Neuropathology of prion diseases
  246. Immunostaining for ubiquitin: efficient pretreatment
  247. Nucleus-specific alteration of raphe neurons in human neurodegenerative disorders
  248. Accumulation of 14-3-3 proteins in glial cytoplasmic inclusions in multiple system atrophy
  249. Mutations of the Prion Protein Gene
  250. The prion protein in human neurodegenerative disorders
  251. Spontaneous mutations in the prion protein gene causing transmissible spongiform encephalopathy
  252. High expression of DNA topoisomerase IIα and Ki-67 antigen is associated with prolonged survival in glioblastoma patients
  253. BSE and variant Creutzfeldt-Jakob disease: never say never
  254. Author reply to previously published correspondence
  255. Oxidative Damage to Nucleic Acids in Human Prion Disease
  256. Aging, the brain and human prion disease
  257. Fibrous meningeal tumours with extensive non-calcifying collagenous whorls and glial fibrillary acidic protein expression: the whorling-sclerosing variant of meningioma
  258. DNA topoisomerase IIα expression in optic pathway gliomas of childhood
  259. Prominent Stress Response of Purkinje Cells in Creutzfeldt–Jakob Disease
  260. Expression of hypoxia-inducible factor-1α in oligodendrogliomas
  261. Inherited prion disease with A117V mutation of the prion protein gene: a novel Hungarian family
  262. Nail-Patella Syndrome Associated with Respiratory Chain Disorder
  263. Reply
  264. Dysembryoplastic Neuroectodermal Tumor: An Ultrastructural Study of Six Cases
  265. Increased incidence of sporadic Creutzfeldt-Jakob disease on the island of Crete associated with a high rate ofPRNP 129-methionine homozygosity in the local population
  266. Alteration of the serotonergic nervous system in fatal familial insomnia
  267. Kynurenic acid metabolism in the brain of HIV-1 infected patients
  268. Neuropathological relationships between Austria and Japan
  269. No tissue damage by chronic deep brain stimulation in Parkinson's disease
  270. Evidence for Oxidative Stress in Experimental Prion Disease
  271. An autosomal dominant early adult-onset distal muscular dystrophy
  272. Deposition of the prion protein (PrP) during the evolution of experimental Creutzfeldt-Jakob disease
  273. Deposition of disease-associated prion protein involves the peripheral nervous system in experimental scrapie
  274. Disease associated prion protein may deposit in the peripheral nervous system in human transmissible spongiform encephalopathies
  275. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects
  276. Early Destruction of the Extracellular Matrix around Parvalbumin-Immunoreactive Interneurons in Creutzfeldt-Jakob Disease
  277. Vascular changes in white matter lesions of Alzheimer's disease
  278. A novel phenotype in familial Creutzfeldt-Jakob disease: Prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein
  279. Neuroaxonal pathology in Creutzfeldt-Jakob disease
  280. Ancestral Origins and Worldwide Distribution of the PRNP 200K Mutation Causing Familial Creutzfeldt-Jakob Disease
  281. Cytopathological alterations and therapeutic approaches in Binswanger's disease
  282. Fatal familial insomnia: a new Austrian family
  283. Development of HIV encephalitis in AIDS and TNF-α regulatory elements
  284. Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease
  285. Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann–Sträussler–Scheinker disease
  286. Blood-brain barrier dysfunction in Binswanger's disease; an immunohistochemical study
  287. Metallothionein overexpression in human brain tumours
  288. Absence of measles virus receptor (CD46) in lesions of subacute sclerosing panencephalitis brains
  289. The human prion diseases: from neuropathology to pathobiology and molecular genetics
  290. Progressive multifocal leukoencephalopathy in AIDS: initial and follow-up CT and MRI
  291. Central nervous system pathology in patients with the Guillain-Barre syndrome
  292. Naturally Occurring Herpes Simplex Encephalitis in a Domestic Rabbit (Oryctolagus cuniculus)
  293. T Cell-mediated ganglionitis associated with acute sensory neuronopathy
  294. Immunohistochemical study of apolipoprotein E in human cerebrovascular white matter lesions
  295. Suprasellar meningioma with expression of glial fibrillary acidic protein: a peculiar variant
  296. Diagnostic value of stereotactic biopsy of cerebral lesions in patients with AIDS
  297. Trilobar holoprosencephaly ("triprosencephaly"): a unique type of cerebral malformation
  298. Neuroaxonal dystrophy in experimental creutzfeldt-jakob disease: Electron microscopical and immunohistochemical demonstration of neurofilament accumulations within affected neurites
  299. Sensory Neuropathies
  300. Diffuse Lewy body disease as substrate of primary lateral sclerosis
  301. The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence
  302. Ultra Structural Pathology of Gerstmann-Sträussler-Scheinker Disease
  303. Tubulovesicular structures in Gerstmann-Str�ussler-Scheinker disease
  304. Clonal Expansion of Hypermutated Measles Virus in a SSPE Brain
  305. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens
  306. Neuronal damage in the cerebral cortex of AIDS brains: a morphometric study
  307. Devic's neuromyelitis optica and Schilder's myelinoclastic diffuse sclerosis
  308. Subacute diencephalic angioencephalopathy: an entity similar to angiodysgenetic necrotizing encephalopathy and Foix-Alajouanine disease
  309. Tubulovesicular structures in human and experimental Creutzfeldt-Jakob disease
  310. Prominent cortical atrophy with neuronal loss as correlate of human immunodeficiency virus encephalopathy
  311. Prion protein mutation in family first reported by Gerstmann, Sträussler, and Scheinker
  312. Neuropathology of Human Immunodeficiency Virus Infection
  313. The Definition of HIV-specific Neuropathology
  314. Determination of proliferative activities in human brain tumor specimens: a comparison of three methods
  315. Progressive multifocal leukoencephalopathy (PML) in AIDS and in the pre-AIDS era
  316. Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation
  317. Argyrophilic nucleolar organizer region proteins (Ag-NORs) in human brain tumors: relations with grade of malignany and proliferation indices
  318. Loss of neurons in the frontal cortex in AIDS brains
  319. Human immunodeficiency virus (HIV) envelope and core proteins in CNS tissues of patients with the acquired immune deficiency syndrome (AIDS)
  320. Cytomegalovirus (CMV) disease of the brain in AIDS and connatal infection: a comparative study by histology, immunocytochemistry and in situ DNA hybridization
  321. Comparison of in situ DNA hybridization (ISH) and immunocytochemistry for diagnosis of herpes simplex virus (HSV) encephalitis in tissue
  322. Pathogenesis of HIV-associated brain lesions: A neuropathological evaluation
  323. Brain pathology induced by infection with the human immunodeficiency virus (HIV)
  324. Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences
  325. Glial fibrillary acidic protein and S-100 protein in human hepatic encephalopathy: Immunocytochemical demonstration of dissociation of two glia-associated proteins
  326. Cross-reactivity between human hemopoietic cells and brain tumors as defined by monoclonal antibodies
  327. Progressive diffuse leukoencephalopathy in patients with acquired immune deficiency syndrome (AIDS)
  328. Glial bundles in spinal nerve roots
  329. Tumoren des Zentralnervensystems
  330. Auge und seine Anhangsgebilde
  331. Supratentorial lobar ependymomas: Reports on the grading and survival periods in 80 cases, including 46 recurrences
  332. Brain Pathology in the Collagen Vascular Diseases
  333. Rabies and Herpes simplex virus encephalitis
  334. Benign mixed glial-mesenchymal tumour (“glio-fibroma”) of the spinal cord
  335. Diagnostic and pathomorphological aspects of glioma multiplicity
  336. Hereditary cerebellar atrophy (Holmes type) with optic atrophy
  337. Spastic paraplegia associated with addison's disease: Adult variant of adreno-leukodystrophy
  338. Primary leptomeningeal sarcomatosis
  339. Partially resected und irradiated cerebellar astrocytoma of childhood: Malignant evolution after 28 years
  340. Primary glioblastoma of the cerebellum
  341. Addendum
  342. Liquorzellbefunde bei primärer diffuser Melanoblastose der Meningen
  343. Tubulovesicular structures are consistently found in prion diseases including vCJD and FFI
  344. Central Pathogenesis of Prion Diseases